Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients. - Facchin S; Buda A; Cardin R; Agbariah N; Zingone F; De Bona M; Zaetta D; Bertani L; Ghisa M; Barberio B; Savarino EV (Therapeutic advances in gastroenterology, 2021)